Rapid Response COVID-19 Antigen Test Kits (Pack of 25)

The Rapid Response^® COVID-19 Antigen Rapid Test is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from human nasopharyngeal secretions, nasal and oropharyngeal secretions from individuals suspected of COVID-19.

The test is intended for use with Nasopharyngeal or Oropharyngeal swab specimens within the first two weeks of symptom onset, and with Nasal swab specimens within 7 days from symptom onset.

The presence of a colored band in the test region indicates a positive result for the SARS-CoV-2 viral antigens, while its absence indicates a negative result. A colored band at the control region serves as a procedural control, indicating that the proper volume of specimen has been added and membrane wicking is working.

Registered for sale in the European Union (CE-marked) and various other international jurisdictions such as Australia (TGA), Brazil (ANVISA).

CLINICAL PERFORMANCE WITH NASOPHARYNGEAL/OROPHARYNGEAL SPECIMENS

CLINICAL PERFORMANCE WITH NASAL SPECIMENS

SAFETY INFORMATION:

How to Correctly Perform Nasopharyngeal and Oropharyngeal Swabs, click here to watch.

The test is for in vitro diagnostic use by healthcare professionals only.